Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sampre Nutritions Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹7.53 |
|---|---|
| Day's Range | ₹7.30 - ₹7.82 |
| Open | ₹7.30 |
| 52 Week Range | ₹07.33 - ₹42.33 |
| Volume | 66,470 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 5.01 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 23.00 |
| TTM EPS (₹) | 0.32 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.66 |
| PAT Margin (%) | -30.54 |
| Face Value (₹) | 5.00 |
| ROCE(%) | -7.39 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 77.65 | 0.0 |
| Expenses | N/A | N/A |
| PBT | -69.95 | 0.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -71.43 | 0.0 |
About Sampre Nutritions Ltd.
| Founded | 1991 |
|---|---|
| Managing Director | BRAHMA GURBANI |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Hindustan Unilever Ltd. | 5,05,420.58 | 2,118.30 | 2,022.50 - 2,022.50 |
| ITC Ltd. | 3,64,356.94 | 287.90 | 275.05 - 275.05 |
| Nestle India Ltd. | 2,67,476.48 | 1,408.60 | 1,084.70 - 1,084.70 |
| Varun Beverages Ltd. | 1,70,586.11 | 504.65 | 381.00 - 381.00 |
| Britannia Industries Ltd. | 1,22,952.43 | 5,138.25 | 5,035.00 - 5,035.00 |
| Marico Ltd. | 1,09,064.46 | 836.75 | 690.20 - 690.20 |
| Godrej Consumer Products Ltd. | 1,04,514.20 | 1,011.25 | 967.05 - 967.05 |
| Dabur India Ltd. | 75,605.85 | 424.45 | 403.35 - 403.35 |
| Colgate-Palmolive (India) Ltd. | 54,363.13 | 1,993.35 | 1,782.00 - 1,782.00 |
| Patanjali Foods Ltd. | 44,895.36 | 410.95 | 407.50 - 407.50 |
No Records Found
Latest News
Sampre Nutritions informs about closure of trading window
Pursuant to Regulation 9 of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the SEBI Circular SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated 19 July 2023 and the Company’s Code of Conduct to regulate, monitor and report trading of designated persons, Sampre Nutritions has informed that the trading window for dealing in securities of the Company will be closed from 01 July 2026 till 48 hours after the declaration of unaudited standalone and consolidated financial results (‘results’) for the first quarter of the financial year 2026-27 ending on 30 June 2026. The date of the meeting of Board of Directors for declaration of the results of the Company for the first quarter ending 30 June 2026 will be intimated in due course. Accordingly, all the promoters / directors / designated persons / specific connected persons of the Company and their immediate relatives are advised not to trade in securities of the Company during the aforesaid trading window closure period.
Sampre Nutritions informs about notice of postal ballot
KSE informs about closure of trading window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s code of conduct for regulating, monitoring, and reporting of trading by insiders, KSE has informed that the Trading Window for trading/dealing in Shares of the Company will remain closed from July 1, 2026 until 48 hours after declaration of Unaudited financial results of the Company for the Quarter ending on 30th June, 2026. During the closure of trading window, all designated persons of the Company (including their immediate relatives) have been advised not to deal in the Shares of the Company. The date of the Board Meeting of the Company for declaration of Unaudited Financial Results for the Quarter year ended 30th June, 2026, will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
KSE informs about press release
Pursuant to the provisions of Regulation 30 of the Listing Regulations, KSE has informed that Umkal Health Care, a wholly owned subsidiary of the Company has today approved the expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, with the addition of 100 new beds. The newly expanded facility will be branded as Park Hospital Platinum and is expected to commence its operation in November, 2026. The press release towards the aforesaid expansion is also enclosed. The details, as required under the Listing Regulations, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are provided in ‘Annexure’ as enclosed. The disclosure is also being disseminated on the Company's website at https://www.parkhospital.in/.
The above information is a part of company’s filings submitted to BSE.
Apis India informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sampre Nutritions Ltd. is ₹7.53 as of 2026-06-30.
The market capitalisation of Sampre Nutritions Ltd. is ₹70.78 as of 2026-06-29.
The 1-year return of Sampre Nutritions Ltd. is -0.91% as of 2025-06-27.
The P/E ratio of Sampre Nutritions Ltd. is 0.00 as of 2026-06-30.
The 52-week high and low of Sampre Nutritions Ltd. are ₹42.33 and ₹7.33, respectively, as of 2026-06-30.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
